2023 Q4 Form 10-Q Financial Statement

#000143774923030285 Filed on November 06, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $53.47M $53.17M
YoY Change -1.5% -9.5%
Cost Of Revenue $20.07M $21.06M
YoY Change -6.74% -5.84%
Gross Profit $33.40M $32.11M
YoY Change 1.94% -11.75%
Gross Profit Margin 62.47% 60.39%
Selling, General & Admin $29.18M $27.18M
YoY Change 18.76% -0.82%
% of Gross Profit 87.35% 84.64%
Research & Development $4.294M $4.993M
YoY Change -10.49% 0.08%
% of Gross Profit 12.86% 15.55%
Depreciation & Amortization $9.049M $8.100M
YoY Change 5.47% 0.56%
% of Gross Profit 27.09% 25.23%
Operating Expenses $33.47M $32.17M
YoY Change 13.98% -0.69%
Operating Profit -$67.00K -$60.00K
YoY Change -101.97% -101.5%
Interest Expense $1.856M $905.0K
YoY Change 59.72% -25.45%
% of Operating Profit
Other Income/Expense, Net $2.013M -$1.265M
YoY Change -235.46% 107.04%
Pretax Income $1.946M -$1.325M
YoY Change 1.57% -139.15%
Income Tax -$170.0K -$95.00K
% Of Pretax Income -8.74%
Net Earnings $2.116M -$1.230M
YoY Change 369.18% -194.18%
Net Earnings / Revenue 3.96% -2.31%
Basic Earnings Per Share $0.39 -$0.23
Diluted Earnings Per Share $0.39 -$0.23
COMMON SHARES
Basic Shares Outstanding 5.392M 5.384M
Diluted Shares Outstanding 5.396M 5.387M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.22M $35.60M
YoY Change 8.13% 9.95%
Cash & Equivalents $28.22M $35.62M
Short-Term Investments
Other Short-Term Assets $4.545M $4.235M
YoY Change 31.89% 19.6%
Inventory $35.97M $32.88M
Prepaid Expenses
Receivables $36.02M $36.34M
Other Receivables $0.00 $0.00
Total Short-Term Assets $118.4M $117.7M
YoY Change 3.65% 1.21%
LONG-TERM ASSETS
Property, Plant & Equipment $31.78M $28.57M
YoY Change 12.43% 1.25%
Goodwill $346.2M $283.3M
YoY Change 21.12% 1.89%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.59M $8.953M
YoY Change 9.63% -17.29%
Total Long-Term Assets $623.4M $519.5M
YoY Change 13.6% -3.79%
TOTAL ASSETS
Total Short-Term Assets $118.4M $117.7M
Total Long-Term Assets $623.4M $519.5M
Total Assets $741.8M $637.2M
YoY Change 11.88% -2.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.554M $4.810M
YoY Change -27.58% -37.84%
Accrued Expenses $15.89M $12.34M
YoY Change 26.02% -0.96%
Deferred Revenue $14.36M $14.32M
YoY Change -1.56% 3.51%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $44.18M $39.82M
YoY Change 6.17% -4.07%
LONG-TERM LIABILITIES
Long-Term Debt $233.0M $170.7M
YoY Change 23.23% -13.27%
Other Long-Term Liabilities $17.32M $5.443M
YoY Change 111.94% -20.26%
Total Long-Term Liabilities $17.32M $5.443M
YoY Change 111.94% -20.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $44.18M $39.82M
Total Long-Term Liabilities $17.32M $5.443M
Total Liabilities $338.8M $249.4M
YoY Change 22.85% -11.55%
SHAREHOLDERS EQUITY
Retained Earnings $71.95M $70.70M
YoY Change -3.35% -5.54%
Common Stock $340.9M $337.9M
YoY Change 4.26% 3.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $403.0M $387.8M
YoY Change
Total Liabilities & Shareholders Equity $741.8M $637.2M
YoY Change 11.88% -2.9%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $2.116M -$1.230M
YoY Change 369.18% -194.18%
Depreciation, Depletion And Amortization $9.049M $8.100M
YoY Change 5.47% 0.56%
Cash From Operating Activities $11.53M $9.780M
YoY Change 49.39% -7.36%
INVESTING ACTIVITIES
Capital Expenditures $1.132M $630.0K
YoY Change -31.56% -138.44%
Acquisitions
YoY Change
Other Investing Activities -$79.70M
YoY Change 1510.1%
Cash From Investing Activities -$80.83M -$630.0K
YoY Change 1123.99% -61.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 60.85M -5.560M
YoY Change -785.01% -70.18%
NET CHANGE
Cash From Operating Activities 11.53M 9.780M
Cash From Investing Activities -80.83M -630.0K
Cash From Financing Activities 60.85M -5.560M
Net Change In Cash -8.453M 3.590M
YoY Change 8.8% -136.9%
FREE CASH FLOW
Cash From Operating Activities $11.53M $9.780M
Capital Expenditures $1.132M $630.0K
Free Cash Flow $10.40M $9.150M
YoY Change 71.47% -24.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
979000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
849000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21324000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19768000 usd
CY2023Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5391726
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5391726
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5369466
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5369466
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
true
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-11740
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-0872291
dei Entity Address Address Line1
EntityAddressAddressLine1
12100 West Sixth Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Lakewood
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80228
dei City Area Code
CityAreaCode
303
dei Local Phone Number
LocalPhoneNumber
987-8000
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
MLAB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5391726
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35617000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32910000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36340000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42551000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
32879000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
34642000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12826000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8872000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
117662000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
118975000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28574000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28149000 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1051000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1076000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8953000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10373000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
283268000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
286444000 usd
CY2023Q3 us-gaap Assets
Assets
637188000 usd
CY2023Q1 us-gaap Assets
Assets
661832000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4810000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
6134000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8353000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9433000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14316000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
15694000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12337000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12098000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
39816000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
43359000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
33437000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
34028000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5443000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7693000 usd
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
13000000 usd
CY2023Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
170733000 usd
CY2023Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
170272000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
249429000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
268352000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
337869000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
332076000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
70699000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
74199000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-20809000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12795000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
387759000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
393480000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
637188000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
661832000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53165000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58749000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
103810000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
109202000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
21056000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
22363000 usd
us-gaap Cost Of Revenue
CostOfRevenue
40518000 usd
us-gaap Cost Of Revenue
CostOfRevenue
41475000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
32109000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
36386000 usd
us-gaap Gross Profit
GrossProfit
63292000 usd
us-gaap Gross Profit
GrossProfit
67727000 usd
CY2023Q3 us-gaap Selling Expense
SellingExpense
9650000 usd
CY2022Q3 us-gaap Selling Expense
SellingExpense
9200000 usd
us-gaap Selling Expense
SellingExpense
18626000 usd
us-gaap Selling Expense
SellingExpense
19223000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17526000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18202000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35586000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38414000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4993000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4989000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9804000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10689000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
32169000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
32391000 usd
us-gaap Operating Expenses
OperatingExpenses
64016000 usd
us-gaap Operating Expenses
OperatingExpenses
68326000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-60000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3995000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-724000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-599000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
905000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
1214000 usd
us-gaap Interest Expense
InterestExpense
1953000 usd
us-gaap Interest Expense
InterestExpense
2228000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-360000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
603000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
415000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
799000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1265000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-611000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1538000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1429000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1325000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3384000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2262000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2028000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-95000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2078000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-483000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1896000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1230000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1306000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1779000 usd
us-gaap Net Income Loss
NetIncomeLoss
-132000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5387000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5323000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5379000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5298000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5387000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5364000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5379000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5298000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1230000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1306000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1779000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-132000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1353000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-13226000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8014000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-29183000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2583000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11920000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9793000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29315000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
393480000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
52000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
712000 usd
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
859000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2968000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6661000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-549000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
387719000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
304000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2000 usd
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
862000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3183000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1353000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1230000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
387759000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
393801000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1438000 usd
CY2022Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2000 usd
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
843000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3432000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15957000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1438000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
380431000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2778000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
572000 usd
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
852000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4371000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-13226000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1306000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
374236000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1779000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-132000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16230000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16189000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6151000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7803000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
461000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
452000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1137000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1544000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5448000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2657000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
184000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4065000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3528000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3052000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1307000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
243000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1743000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5869000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1171000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
378000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19715000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7746000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
904000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1864000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-904000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1864000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
13000000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
22000000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
1721000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
1695000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
356000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4216000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
714000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
574000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15079000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20053000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1025000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2798000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2707000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16969000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32910000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
49346000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35617000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32377000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i><b>Prior Period Reclassifications</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Certain prior year amounts presented have been reclassified to conform with current presentation. The reclassifications have <em style="font: inherit;">not</em> resulted in any changes to consolidated or segment amounts reported in the Consolidated Financial Statements for any periods presented in this Form <em style="font: inherit;">10</em>-Q.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"></p>
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53165000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58749000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
103810000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
109202000 usd
CY2023Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1376000 usd
CY2023Q3 us-gaap Prepaid Taxes
PrepaidTaxes
3534000 usd
CY2023Q1 us-gaap Prepaid Taxes
PrepaidTaxes
953000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
4235000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53165000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58749000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
103810000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
109202000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
16098000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6399000 usd
mlab Contract With Customer Liability Increase During Period Net Of Revenue Recognized
ContractWithCustomerLiabilityIncreaseDuringPeriodNetOfRevenueRecognized
4934000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
14633000 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
20203000 usd
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
20064000 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
633000 usd
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
617000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12043000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13961000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
32879000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
34642000 usd
CY2023Q3 mlab Prepaid Expenses Current
PrepaidExpensesCurrent
3494000 usd
CY2023Q1 mlab Prepaid Expenses Current
PrepaidExpensesCurrent
2498000 usd
CY2023Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1563000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
4045000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12826000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8872000 usd
CY2023Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
3317000 usd
CY2023Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4461000 usd
CY2023Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2139000 usd
CY2023Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2329000 usd
CY2023Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1854000 usd
CY2023Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1982000 usd
CY2023Q3 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
1043000 usd
CY2023Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
661000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8353000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9433000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2784000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2868000 usd
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
343000 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
992000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3131000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2297000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12337000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12098000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
322556000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
124876000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
197680000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
328990000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
112175000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
216815000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7185000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7106000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14405000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14426000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
13803000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
26523000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
25765000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
25270000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
24825000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
286444000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-4017000 usd
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
841000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
283268000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3183000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4371000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6151000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7803000 usd
CY2023Q3 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
1389000 usd
CY2022Q3 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-89000 usd
mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
517000 usd
mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-2081000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
4572000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
4282000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
6668000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
5722000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
163000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
200.62
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y3M18D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1643000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
53000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
131.67
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
15000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
213.22
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
132.4
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
199000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
181.9
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y8M12D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1230000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1306000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1779000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-132000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5387000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5323000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5379000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5298000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5387000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5364000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5379000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5298000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
933000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
822000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
904000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
988000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.214 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.935 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53165000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58749000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
103810000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
109202000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
32109000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
36386000 usd
us-gaap Gross Profit
GrossProfit
63292000 usd
us-gaap Gross Profit
GrossProfit
67727000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
32879000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
34642000 usd

Files In Submission

Name View Source Status
0001437749-23-030285-index-headers.html Edgar Link pending
0001437749-23-030285-index.html Edgar Link pending
0001437749-23-030285.txt Edgar Link pending
0001437749-23-030285-xbrl.zip Edgar Link pending
ex_555366.htm Edgar Link pending
ex_555367.htm Edgar Link pending
ex_555368.htm Edgar Link pending
ex_555369.htm Edgar Link pending
mlab-20230930_cal.xml Edgar Link unprocessable
ex_585625.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mlab-20230930.xsd Edgar Link pending
mlab20230930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
mlab-20230930_pre.xml Edgar Link unprocessable
mlab-20230930_def.xml Edgar Link unprocessable
mlab-20230930_lab.xml Edgar Link unprocessable
mlab20230930_10q_htm.xml Edgar Link completed
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable